TrialClinical pharmacology and therapeutics2025

Optimizing Brentuximab Vedotin Dosing in Pediatric Patients with Advanced Hodgkin Lymphoma: A Population Pharmacokinetic and Exposure-Response Analysis.

Xiaofei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.